| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-13 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-09 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-09 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-08 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-08 |